In Spring 2004, IHCC team discovered that CHEK2 gene can be used as indicator of of predispositions to several common types of cancer (including prostate, breast and colon). This discovery was published by American Journal for Human Genetics. It received extensive media coverage in Poland, not only from the leading daily, Gazeta Wyborcza, but also from national radio and TV networks.